Children's Hospital Boston Pediatric Medicine

Boston, Massachusetts 02115

0 studies enrolling now · 1 studies all time

What they study most

Juvenile Idiopathic Arthritis

Studies at this site

• A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) — Completed